Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions

PHASE4CompletedINTERVENTIONAL
Enrollment

2,645

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Coronary Artery Disease
Interventions
DEVICE

Endeavor

Zotarolimus-eluting stent

DEVICE

Cypher

Sirolimus-eluting stent

DEVICE

Taxus Liberte

Paclitaxel-eluting stent

Trial Locations (20)

Unknown

Soonchunhyang University Bucheon Hospital, Bucheon-si

Daegu Catholic University Medical Center, Daegu

Keimyung University Dongsan Medical Center, Daegu

Kyungpook National University Hospital, Daegu

Chungnam National University Hospital, Daejeon

Asan Medical Center, Gangneung

Chonnam National University Hospital, Gwangju

NHIC Ilsan Hospital, Ilsan

Chonbuk National University Hospital, Jeonju

Pusan Natioanal University Hospital, Pusan

Hallym University Sacred Heart Hospital, Pyeongchon

Seoul National University Bundang Hospital, Seongnam

Korea University Hospital, Seoul

Seoul National University Hospital, Seoul

St.Mary's Catholic Medical Center, Seoul

Yonsei University Medical Center, Seoul

Ajou University Hospital, Suwon

Ulsan University Hospital, Ulsan

Yonsei University Wonju Christian Hospital, Wŏnju

138-736

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic Vascular

INDUSTRY

lead

Seung-Jung Park

OTHER